Lilly says weight loss drug cuts heart failure risk by 38% in trial – Reuters

0
56


  1. Lilly says weight loss drug cuts heart failure risk by 38% in trial  Reuters
  2. CrowdStrike Stock Had an Awful July. The Best Performer Might Be a Surprise.  Barron’s
  3. Live news: Warner Music shakeup includes major promotion for son of Universal Music CEO  Financial Times
  4. Eli Lilly says tirzepatide showed positive results in late-stage trial evaluating it as treatment for heart failure  MarketWatch
  5. Lilly’s tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity  Investors | Eli Lilly and Company


LEAVE A REPLY

Please enter your comment!
Please enter your name here